Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 57,528 shares at $32.57 ($1.9M) on 2021-08-18, disclosed to the SEC on 2021-08-20.
Open-market sale of $1.9M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.57 | 11,431 | $372K | 19.5% |
| 2 | $32.57 | 11,431 | $372K | 19.5% |
| 3 | $33.84 | 13,196 | $447K | 23.4% |
| 4 | $33.84 | 13,196 | $447K | 23.4% |
| 5 | $34.32 | 2,237 | $77K | 4.0% |
| 6 | $34.32 | 2,237 |
| $77K |
| 4.0% |
| 7 | $30.97 | 3,800 | $118K | 6.2% |
| Total | $33.18 avg | 57,528 | $1.9M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |